Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Equillium
AddedFeb 19, 2024
UpdatedJun 18, 2026
Equillium

Equillium

Public

Equillium, Inc.: A clinical-stage biotech firm in California, innovating solutions for autoimmune and inflammatory disorders.

HQ
Los Angeles, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Equillium, Inc. is a clinical-stage biotechnology company founded with the mission to develop innovative solutions for severe autoimmune and inflammatory disorders. Based in California, the company's vision centers on leveraging a deep understanding of immunobiology to create treatments that restore immune system balance. Equillium focuses on addressing high unmet medical needs through its pioneering products, including those currently in clinical trials for conditions such as acute graft-versus-host disease.

Notable figures affiliated with Equillium include its leadership team and scientific advisors, who bring extensive expertise in immunobiology and drug development. The company has attracted significant investment from prominent biotech investors, underscoring confidence in its potential. Key achievements include advancing multiple drug candidates into clinical trials and demonstrating promising efficacy and safety profiles. Equillium's impact lies in its commitment to transforming the lives of patients suffering from debilitating autoimmune and inflammatory conditions.

Equillium - Similar Companies

Q32 Bio logo

Q32 Bio

q32bio.com

HI-Bio logo

HI-Bio

hibio.com

Thelium Therapeutics logo

Thelium Therapeutics

Kezar Life Sciences logo

Kezar Life Sciences

Endpoint Health logo

Endpoint Health

Halia Therapeutics logo

Halia Therapeutics

Santa Ana Bio logo

Santa Ana Bio

santaanabio.com

Equator Therapeutics logo

Equator Therapeutics

Imidomics logo

Imidomics

imidomics.com

INmune Bio logo

INmune Bio

inmunebio.com

Forte Biosciences logo

Forte Biosciences

fortebiorx.com

Entelexo Biotherapeutics logo

Entelexo Biotherapeutics

entelexo.com

Tr1x logo

Tr1x

tr1x.bio

Eikon Therapeutics logo

Eikon Therapeutics

eikontx.com

Nantkwest logo

Nantkwest

Equillium - Quick Facts

Who are Equillium's competitors?

Companies similar to Equillium include Q32 Bio, HI-Bio, Thelium Therapeutics and Kezar Life Sciences.

When was Equillium founded?

Equillium was founded in 2017.

Where is Equillium's headquarters located?

Equillium's headquarters is located in Los Angeles, CA, US.

When was Equillium's last funding round?

Equillium's most recent funding round was for $30M (USD) in February 2021.

How much has Equillium raised to-date?

As of Feb 4, 2021, Equillium has raised a total of $85M (USD).

How many employees does Equillium have?

Equillium has 45 employees as of Feb 6, 2024.

Equillium - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biotechnology
Tags
  • Healthtech
Unique IDs
  • ein: 821554746
  • secCik: 0001746466
  • ticker: EQ
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research